Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Polarize is a Danish medical technology company specializing in hyperpolarization technology to revolutionize Magnetic Resonance Imaging (MRI). Spun out from the Technical University of Denmark, the company develops Dissolution Dynamic Nuclear Polarization (d-DNP) systems that increase MRI signal sensitivity by over 10,000-fold. This enables real-time, non-invasive visualization of metabolic processes in vivo, providing critical insights into diseases such as cancer and heart failure. Polarize offers both hardware solutions and specialized consumables to research institutions and clinical researchers worldwide. Their technology aims to transform diagnostic imaging by moving beyond anatomy to functional metabolic assessment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Polarize.